Description

Comparative affinity of major phytocannabinoids at serotonin receptor subtypes. Cannabidiol shows notable 5-HT1A agonist activity, while other phytocannabinoids display distinct serotonergic profiles.

Figure 155

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 155: Comparative affinity of major phytocannabinoids at serotonin receptor subtypes. Cannabidiol shows notable 5-HT1A agonist activity, while other phytocannabinoids display distinct serotonergic profiles.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Comparative affinity of major phytocannabinoids at serotonin receptor subtypes. Cannabidiol shows notable 5-HT1A agonist activity, while other phytocannabinoids display distinct serotonergic profiles." />
  <figcaption>Figure 155. Comparative affinity of major phytocannabinoids at serotonin receptor subtypes. Cannabidiol shows notable 5-HT1A agonist activity, while other phytocannabinoids display distinct serotonergic profiles.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Related Evidence

CBD for Insomnia

Grade A · 103 studies